SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001005201-19-000075
Filing Date
2019-05-09
Accepted
2019-05-09 11:29:36
Documents
1
Period of Report
2019-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155741575205363.html 4  
1 FORM 4 wf-form4_155741575205363.xml 4 5638
  Complete submission text file 0001005201-19-000075.txt   7127
Mailing Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045
Business Address 100 SOUTH SAUNDERS RD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Therapeutics, Inc (Issuer) CIK: 0001005201 (see all company filings)

IRS No.: 943229046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALLERGAN, INC. 2525 DUPONT DRIVE IRVINE CA 92612
Business Address
LAVIGNE LOUIS J JR (Reporting) CIK: 0001214127 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-13111 | Film No.: 19809461